Iroko, Litha Healthcare, Endo deal

Iroko granted Endo’s Litha Healthcare Group company exclusive rights to develop and commercialize Zorvolex submicron diclofenac in African countries. The countries include Angola, Botswana, Lesotho, Madagascar, Malawi, Mauritius, Mozambique, Namibia, Seychelles, South Africa, Swaziland, Tanzania and Zambia. Litha will be responsible for obtaining regulatory and pricing approval in those countries. ...